Advertisement

Topics

Hoffmann-La Roche Inc. Company Profile

16:20 EST 17th November 2017 | BioPortfolio


News Articles [752 Associated News Articles listed on BioPortfolio]

F. Hoffmann-La Roche: Alliance Management: An Exclusive Interview

Fintan Walton talks to Eric de La Fortelle, Global Head, External Research and Technology, F. Hoffmann-La Roche, about his role within the Pharma Partnering Group at Roche. Eric outlines the structure...

F. Hoffmann-La Roche: Restructuring - An Exclusive Interview with Eric de La Fortelle

In this exclusive interview, Fintan Walton talks to Eric de La Fortelle, Global Head, External Research and Technology, F. Hoffmann-La Roche, about the global restructuring of Roche’s research and d...

Roche: Partnering and Global Activity

In this episode of PharmaTelevision News Review, Fintan Walton talks with Bardia Akbari, Global Head of Partnering, Inflammation and AutoImmune at Hoffmann-La Roche. Filmed at AusBiotech 2009, they di...

Dermira Enters into Agreement for Global Rights to Roche’s IL-13 Drug Lebrikizumab

MENLO PARK, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) — Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering dif...

Physicochemical and biological characterization study of copy biological tocilizumab

Researchers in China have developed a copy biological of F. Hoffmann-La Roche’s  (Roche) arthritis treatment Actemra (tocilizumab). A recent study compares it to the originator, finding it to b...

Pharmaceutical giant Roche funds concept study aiming to find cure for Angelman syndrome

A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world’s largest pharmaceutical and diagnostics compa...

Deals this week: Harbin Gloria Pharmaceuticals, F. Hoffmann-La Roche, Intrexon

Chinese pharmaceutical company Harbin Gloria Pharmaceuticals intends to issue medium-term notes due 2019 in a public offering to raise CNY1.6bn ($243.13m).

FDA approves alectinib as first-line treatment for ALK positive NSCLC

The U.S. Food and Drug Administration has granted regular approval to alectinib (ALECENSA, Hoffmann-La Roche, Inc./Genentech, Inc.) for treatment of patients with anaplastic lymphoma kinase (ALK)-posi...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Toradol oral(ketorolac tromethamine tablets) [Hoffmann-La Roche Inc.]

TORADOL ORAL(ketorolac tromethamine tablets)

Hivid (zalcitabine) tablets [Roche Pharmaceuticals]

HIVID (zalcitabine) TABLETS

Fansidarbrand ofsulfadoxine and pyrimethaminetablets [Roche Pharmaceuticals]

FANSIDARbrand ofsulfadoxine and pyrimethamineTABLETS

Targretin [Eisai Inc.]

Targretin® (bexarotene) capsules, 75 mg

Invirase [State of Florida DOH Central Pharmacy]

INVIRASE (saquinavir mesylate) CAPSULES and TABLETS

PubMed Articles [39 Associated PubMed Articles listed on BioPortfolio]

Comparison between Roche and Xpert in HIV-1 RNA quantitation: A high concordance between the two techniques except for a CRF02_AG subtype variant with high viral load titters detected by Roche but undetected by Xpert.

HIV-1 viral load (VL) testing is important to predict viral progression and to monitor the response to antiretroviral therapy. New HIV-1 VL tests are continuously introduced to the market. Their perfo...

Evaluation of metagenetic community analysis of planktonic copepods using Illumina MiSeq: Comparisons with morphological classification and metagenetic analysis using Roche 454.

Metagenetics is a rapid and taxonomically comprehensive method for revealing community structures within environmental samples, based on large amounts of sequence data produced by high-throughput sequ...

Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing.

The improvement in sensitive techniques has allowed the detection of tumor-specific aberrations in circulating tumor (ct) DNA. Amplification-refractory mutation system PCR has been used for the analys...

Blood feud erupts over Roche's bispecific antibody for hemophilia.

Letter by Czihal and Hoffmann Regarding Article, "Prevalence of Tibial Artery and Pedal Arch Patency by Angiography in Patients With Critical Limb Ischemia and Noncompressible Ankle Brachial Index".

Clinical Trials [45 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps (Pharmacare PLC, Palestine) and Tamiflu® 75 mg Caps (Hoffmann-La Roche, Switzerland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Oseltamivir from Oseltamivir 75 mg capsules (Pharmacare PLC, Palestine) and Tami...

The Effect of Xenical on Weight and Risk Factors

The purpose of this study is to determine the effect of using the weight loss medication Xenical (generic name - orlistat) on weight loss and change in heart disease risk factors in patien...

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols.

This single arm study will provide treatment or re-treatment with PEGASYS as monotherapy or in combination with ribavirin (Copegus), to patients with chronic hepatitis C (CHC) who have par...

Utility of Point-of-care Device for Rapid Determination of Cogulopathy in Trauma Patients

Traumatic coagulopathy is frequent and is an independent risk factor of mortality. Its detection mainly relies upon classic biological test like the prothrombin time and the international ...

Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in De Novo Adult Renal Transplant Recipients

This study will evaluate the safety and efficacy of FTY720 versus mycophenolate mofetil (MMF, Roche brand) combined with cyclosporine and corticosteroids in patients receiving a kidney tra...

Companies [82 Associated Companies listed on BioPortfolio]

Roche Pharmaceuticals

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses ...

Hoffmann-La Roche Inc.

F. Hoffmann-La Roche Ltd

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, ...

Roche Diagnostics, Inc.

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with trul...

Roche Diagnostics GmbH

Nil

More Information about "Hoffmann-La Roche Inc." on BioPortfolio

We have published hundreds of Hoffmann-La Roche Inc. news stories on BioPortfolio along with dozens of Hoffmann-La Roche Inc. Clinical Trials and PubMed Articles about Hoffmann-La Roche Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hoffmann-La Roche Inc. Companies in our database. You can also find out about relevant Hoffmann-La Roche Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record